MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3748/wjg.v18.i8.767

Медицинская библиотека · World journal of gastroenterology · 2012

Rifaximin vs. conventional oral therapy for hepatic encephalopathy: a meta-analysis.

Eltawil Karim M, Laryea Marie, Peltekian Kevork, Molinari Michele

СтатьяМетаанализСистематический обзорПеревод в очереди

Аннотация

AIM: To characterize the efficacy of rifaximin in the management of hepatic encephalopathy (HE) as several randomized controlled studies have shown contradictory results on its effectiveness in comparison to other oral agents.

METHODS

We performed a systematic review and random effects meta-analysis of all eligible trials identified through electronic and manual searches. Twelve randomized controlled trials met the inclusion criteria with a total of 565 patients.

RESULTS

The clinical effectiveness of rifaximin was equivalent to disaccharides or other oral antibiotics [odds ratio (OR) 0.96; 95% CI: 0.94-4.08] but with a better safety profile (OR 0.27; 95% CI: 0.12-0.59). At the completion of treatment protocols, patients receiving rifaximin showed lower serum ammonia levels [weighted mean difference (WMD) = -10.65; 95% CI: -23.4-2.1; P = 0.10], better mental status (WMD = -0.24; 95% CI: -0.57-0.08; P = 0.15) and less asterixis (WMD -0.1; 95% CI -0.26-0.07; P = 0.25) without reaching statistical significance. On the other hand, other psychometric outcomes such as electroencephalographic response and grades of portosystemic encephalopathy were superior in patients treated with rifaximin in comparison to the control group (WMD = 0.21, 95% CI: -0.33-0.09, P = 0.0004; and WMD = -2.33, 95% CI: -2.68-1.98, P = 0.00001, respectively). Subgroup and sensitivity analysis did not show any significant difference in the above findings.

CONCLUSION

Rifaximin appears to be at least as effective as other conventional oral agents for the treatment of HE with a better safety profile.

Для цитирования: Eltawil Karim M, Laryea Marie, Peltekian Kevork, Molinari Michele. Rifaximin vs. conventional oral therapy for hepatic encephalopathy: a meta-analysis.. World journal of gastroenterology. 2012. DOI: 10.3748/wjg.v18.i8.767.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.